Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA

K-Number: K854550 · 1985-12-19

ApplicantMedipart Jerry Alexander
Decision Date1985-12-19
Product CodeCCQ
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA is the device name listed in this FDA 510(k) record. The listed applicant is Medipart Jerry Alexander. It received FDA 510(k) clearance on 1985-12-19 under 510(k) number K854550. The device is classified under product code CCQ. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA?

MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA is a medical device that received FDA 510(k) clearance on 1985-12-19. The listed applicant is Medipart Jerry Alexander. The 510(k) number is K854550.

When did MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA receive FDA 510(k) clearance?

MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA received FDA 510(k) clearance on 1985-12-19, under 510(k) number K854550.

Who is the listed applicant for MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA?

The FDA 510(k) record lists Medipart Jerry Alexander as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA?

The FDA product code for MEDIPART REMOTE INJECTION SYS FOR ULTRAVENT RADIOA is CCQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medipart Jerry Alexander as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K896885DISPOSABLE RESPIRTORY KIT (MP-200)K896125MEDIPART DISPOSABLE XENON-133 REBREATHING MP-0133MK896475DISP. RADIOAEROSOL KIT (MP-400) TO FIT LEAD SHIELDK896124MEDIPART DISPOSABLE XENON-133 REBREATHING MP-0133K896476DISP. RADIOAEROSOL KIT (MP-400-M) TO FIT SHIELDK894138MEDIPART DISPOSABLE AEROSOL SYSTEM MP-070-PTD

View all 49 devices →

Related Devices (Code: CCQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K972397EZ SPRAYIntertex Research, Inc.K964956E-Z SPACER MASK (SMALL)Airpharma, LLCK961894MDI TUTORMdi Tutor, Inc.K961455MEDSHIELD/AEROCHAMBERDiemolding Corp.K960593SMARTMIST ASTHMA MANAGMENT SYSTEM, SMARTMIST, MODEL NUMBER SM-100/SMARTMIST SPIROMETRY AIRWAY, MODEL NUMBER SA-100Aradigm Corp.K922033SALINE SOLUTION- STERILETrinity Laboratories, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑